Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline

2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) is one of several mutagenic and carcinogenic heterocyclic amines formed during the cooking process of protein-rich foods. These compounds are highly mutagenic and have been shown to produce tumours in various tissues in rodents and non-human primates. Met...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Carcinogenesis (New York) 2000-06, Vol.21 (6), p.1213-1219
Hauptverfasser: Agus, Cynthia, Ilett, Kenneth F., Kadlubar, Fred F., Minchin, Rodney F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1219
container_issue 6
container_start_page 1213
container_title Carcinogenesis (New York)
container_volume 21
creator Agus, Cynthia
Ilett, Kenneth F.
Kadlubar, Fred F.
Minchin, Rodney F.
description 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) is one of several mutagenic and carcinogenic heterocyclic amines formed during the cooking process of protein-rich foods. These compounds are highly mutagenic and have been shown to produce tumours in various tissues in rodents and non-human primates. Metabolic activation of IQ is a two-step process involving N-hydroxylation by CYP1A2 followed by esterification to a more reactive species capable of forming adducts with DNA. To date, acetylation and sulphation have been proposed as important pathways in the formation of N-hydroxy esters. In this study we have demonstrated the presence of an ATP-dependent activation pathway for N-hydroxy-IQ (N-OH-IQ) leading to DNA adduct formation measured by covalent binding of [3H]N-OH-IQ to DNA. ATP-dependent DNA binding of N-OH-IQ was greatest in the cytosolic fraction of rat liver, although significant activity was also seen in colon, pancreas and lung. ATP was able to activate N-OH-IQ almost 10 times faster than N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (7.7 ± 0.3 and 0.9 ± 0.1 pmol/mg protein/min, respectively). Using reported intracellular concentrations of cofactor, the ability of ATP to support DNA binding was similar to that seen with 3′-phosphoadenosine 5′-phosphosulphate and ~50% of that seen with acetyl coenzyme A (AcCoA). In addition to DNA binding, HPLC analysis of the reaction mixtures using ATP as co-factor showed the presence of two stable, polar metabolites. With AcCoA, only one metabolite was seen. The kinase inhibitors genistein, tyrphostin A25 and rottlerin significantly inhibited both DNA binding and metabolite formation with ATP. However, inhibition was unlikely to be due to effects on enzyme activity since the broad spectrum kinase inhibitor staurosporine had no effect and the inactive analogue of genistein, daidzein, was as potent as genistein. The effects of genistein and daidzein, which are naturally occurring isoflavones from soy and other food products, on DNA adduct formation may potentially be useful in the prevention of heterocyclic amine-induced carcinogenesis.
doi_str_mv 10.1093/carcin/21.6.1213
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17550532</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17550532</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-afcdbf78895902e127fd00649d289304e3f6dbbc0b21aa163714d55ef85403eb3</originalsourceid><addsrcrecordid>eNpdkctu1DAYhS0EotOBPSsUoaorPPUlzmVZRcCAKmAxSAiELMcX4pLYUzuBpo_BE-MhI0CsvDjf9_u3DwBPMNpgVNMLKYK07oLgTbHBBNN7YIXzAkGCK3QfrBDOKaSU5ifgNMZrhHBBWf0QnGBU0RJhsgI_m04EIUcd7J0YrXeZN5lw2eXuPVR6r53Sbsz2Yux-iPl3Jkf7fSGND9nY6azTSfdylr2VmRis09mymP-qXfYWdrMK_naGBB5CDykc9NjNvR2sEnf-c_6cQfPlZkpZn-RH4IERfdSPj-cafHj5Ytds4dW7V6-byyso84KMUBipWlNWVc1qRDQmpVEIFXmtSFVTlGtqCtW2ErUEC5FeXuJcMaZNxXJEdUvX4HyZuw_-ZtJx5IONUve9cNpPkeOSMcQoSeCz_8BrPwWXduMEp6tqVBwgtEAy-BiDNnwf7CDCzDHih7L48idJ4QU_lJWUp8e5Uzto9Y-wtJOAsyMgohS9CcJJG_9yOaYosWsAF8zGUd_-iUX4xouSloxvP37iDXmz21YN4yX9BdMLrmQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219309062</pqid></control><display><type>article</type><title>Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><source>Oxford Journals</source><creator>Agus, Cynthia ; Ilett, Kenneth F. ; Kadlubar, Fred F. ; Minchin, Rodney F.</creator><creatorcontrib>Agus, Cynthia ; Ilett, Kenneth F. ; Kadlubar, Fred F. ; Minchin, Rodney F.</creatorcontrib><description>2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) is one of several mutagenic and carcinogenic heterocyclic amines formed during the cooking process of protein-rich foods. These compounds are highly mutagenic and have been shown to produce tumours in various tissues in rodents and non-human primates. Metabolic activation of IQ is a two-step process involving N-hydroxylation by CYP1A2 followed by esterification to a more reactive species capable of forming adducts with DNA. To date, acetylation and sulphation have been proposed as important pathways in the formation of N-hydroxy esters. In this study we have demonstrated the presence of an ATP-dependent activation pathway for N-hydroxy-IQ (N-OH-IQ) leading to DNA adduct formation measured by covalent binding of [3H]N-OH-IQ to DNA. ATP-dependent DNA binding of N-OH-IQ was greatest in the cytosolic fraction of rat liver, although significant activity was also seen in colon, pancreas and lung. ATP was able to activate N-OH-IQ almost 10 times faster than N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (7.7 ± 0.3 and 0.9 ± 0.1 pmol/mg protein/min, respectively). Using reported intracellular concentrations of cofactor, the ability of ATP to support DNA binding was similar to that seen with 3′-phosphoadenosine 5′-phosphosulphate and ~50% of that seen with acetyl coenzyme A (AcCoA). In addition to DNA binding, HPLC analysis of the reaction mixtures using ATP as co-factor showed the presence of two stable, polar metabolites. With AcCoA, only one metabolite was seen. The kinase inhibitors genistein, tyrphostin A25 and rottlerin significantly inhibited both DNA binding and metabolite formation with ATP. However, inhibition was unlikely to be due to effects on enzyme activity since the broad spectrum kinase inhibitor staurosporine had no effect and the inactive analogue of genistein, daidzein, was as potent as genistein. The effects of genistein and daidzein, which are naturally occurring isoflavones from soy and other food products, on DNA adduct formation may potentially be useful in the prevention of heterocyclic amine-induced carcinogenesis.</description><identifier>ISSN: 0143-3334</identifier><identifier>EISSN: 1460-2180</identifier><identifier>DOI: 10.1093/carcin/21.6.1213</identifier><identifier>PMID: 10837012</identifier><identifier>CODEN: CRNGDP</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>2-amino-3-methylimidazo ; 5-b]pyridine ; 5-f]quinoline ; Acetylation ; Adenosine Triphosphate - metabolism ; Animals ; Biological and medical sciences ; Biotransformation ; Carcinogenesis, carcinogens and anticarcinogens ; Carcinogens - pharmacokinetics ; Chemical agents ; dimethyl sulphoxide ; dithiothreitol ; DMSO ; DNA - metabolism ; DTT ; Enzyme Inhibitors - pharmacology ; GSH ; Humans ; Imidazoles - pharmacokinetics ; Kinetics ; Male ; Medical sciences ; N-hydroxy-2-amino-1-methyl-6-phenylimidazo ; N-Hydroxy-2-amino-3-methylimidazo(4,5-f)quinoline ; N-hydroxy-IQ ; N-OH-IQ ; N-OH-PhIP ; Phosphotransferases - antagonists &amp; inhibitors ; PKC ; protein kinase C ; Quinolines - pharmacokinetics ; Rats ; Rats, Inbred F344 ; reduced glutathione ; Subcellular Fractions - metabolism ; Sulfuric Acids - metabolism ; tetrahydrofuran ; THF ; Tumors</subject><ispartof>Carcinogenesis (New York), 2000-06, Vol.21 (6), p.1213-1219</ispartof><rights>2000 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Jun 2000</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-afcdbf78895902e127fd00649d289304e3f6dbbc0b21aa163714d55ef85403eb3</citedby><cites>FETCH-LOGICAL-c462t-afcdbf78895902e127fd00649d289304e3f6dbbc0b21aa163714d55ef85403eb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1413008$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10837012$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Agus, Cynthia</creatorcontrib><creatorcontrib>Ilett, Kenneth F.</creatorcontrib><creatorcontrib>Kadlubar, Fred F.</creatorcontrib><creatorcontrib>Minchin, Rodney F.</creatorcontrib><title>Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline</title><title>Carcinogenesis (New York)</title><addtitle>Carcinogenesis</addtitle><description>2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) is one of several mutagenic and carcinogenic heterocyclic amines formed during the cooking process of protein-rich foods. These compounds are highly mutagenic and have been shown to produce tumours in various tissues in rodents and non-human primates. Metabolic activation of IQ is a two-step process involving N-hydroxylation by CYP1A2 followed by esterification to a more reactive species capable of forming adducts with DNA. To date, acetylation and sulphation have been proposed as important pathways in the formation of N-hydroxy esters. In this study we have demonstrated the presence of an ATP-dependent activation pathway for N-hydroxy-IQ (N-OH-IQ) leading to DNA adduct formation measured by covalent binding of [3H]N-OH-IQ to DNA. ATP-dependent DNA binding of N-OH-IQ was greatest in the cytosolic fraction of rat liver, although significant activity was also seen in colon, pancreas and lung. ATP was able to activate N-OH-IQ almost 10 times faster than N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (7.7 ± 0.3 and 0.9 ± 0.1 pmol/mg protein/min, respectively). Using reported intracellular concentrations of cofactor, the ability of ATP to support DNA binding was similar to that seen with 3′-phosphoadenosine 5′-phosphosulphate and ~50% of that seen with acetyl coenzyme A (AcCoA). In addition to DNA binding, HPLC analysis of the reaction mixtures using ATP as co-factor showed the presence of two stable, polar metabolites. With AcCoA, only one metabolite was seen. The kinase inhibitors genistein, tyrphostin A25 and rottlerin significantly inhibited both DNA binding and metabolite formation with ATP. However, inhibition was unlikely to be due to effects on enzyme activity since the broad spectrum kinase inhibitor staurosporine had no effect and the inactive analogue of genistein, daidzein, was as potent as genistein. The effects of genistein and daidzein, which are naturally occurring isoflavones from soy and other food products, on DNA adduct formation may potentially be useful in the prevention of heterocyclic amine-induced carcinogenesis.</description><subject>2-amino-3-methylimidazo</subject><subject>5-b]pyridine</subject><subject>5-f]quinoline</subject><subject>Acetylation</subject><subject>Adenosine Triphosphate - metabolism</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biotransformation</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Carcinogens - pharmacokinetics</subject><subject>Chemical agents</subject><subject>dimethyl sulphoxide</subject><subject>dithiothreitol</subject><subject>DMSO</subject><subject>DNA - metabolism</subject><subject>DTT</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>GSH</subject><subject>Humans</subject><subject>Imidazoles - pharmacokinetics</subject><subject>Kinetics</subject><subject>Male</subject><subject>Medical sciences</subject><subject>N-hydroxy-2-amino-1-methyl-6-phenylimidazo</subject><subject>N-Hydroxy-2-amino-3-methylimidazo(4,5-f)quinoline</subject><subject>N-hydroxy-IQ</subject><subject>N-OH-IQ</subject><subject>N-OH-PhIP</subject><subject>Phosphotransferases - antagonists &amp; inhibitors</subject><subject>PKC</subject><subject>protein kinase C</subject><subject>Quinolines - pharmacokinetics</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>reduced glutathione</subject><subject>Subcellular Fractions - metabolism</subject><subject>Sulfuric Acids - metabolism</subject><subject>tetrahydrofuran</subject><subject>THF</subject><subject>Tumors</subject><issn>0143-3334</issn><issn>1460-2180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkctu1DAYhS0EotOBPSsUoaorPPUlzmVZRcCAKmAxSAiELMcX4pLYUzuBpo_BE-MhI0CsvDjf9_u3DwBPMNpgVNMLKYK07oLgTbHBBNN7YIXzAkGCK3QfrBDOKaSU5ifgNMZrhHBBWf0QnGBU0RJhsgI_m04EIUcd7J0YrXeZN5lw2eXuPVR6r53Sbsz2Yux-iPl3Jkf7fSGND9nY6azTSfdylr2VmRis09mymP-qXfYWdrMK_naGBB5CDykc9NjNvR2sEnf-c_6cQfPlZkpZn-RH4IERfdSPj-cafHj5Ytds4dW7V6-byyso84KMUBipWlNWVc1qRDQmpVEIFXmtSFVTlGtqCtW2ErUEC5FeXuJcMaZNxXJEdUvX4HyZuw_-ZtJx5IONUve9cNpPkeOSMcQoSeCz_8BrPwWXduMEp6tqVBwgtEAy-BiDNnwf7CDCzDHih7L48idJ4QU_lJWUp8e5Uzto9Y-wtJOAsyMgohS9CcJJG_9yOaYosWsAF8zGUd_-iUX4xouSloxvP37iDXmz21YN4yX9BdMLrmQ</recordid><startdate>20000601</startdate><enddate>20000601</enddate><creator>Agus, Cynthia</creator><creator>Ilett, Kenneth F.</creator><creator>Kadlubar, Fred F.</creator><creator>Minchin, Rodney F.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20000601</creationdate><title>Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline</title><author>Agus, Cynthia ; Ilett, Kenneth F. ; Kadlubar, Fred F. ; Minchin, Rodney F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-afcdbf78895902e127fd00649d289304e3f6dbbc0b21aa163714d55ef85403eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>2-amino-3-methylimidazo</topic><topic>5-b]pyridine</topic><topic>5-f]quinoline</topic><topic>Acetylation</topic><topic>Adenosine Triphosphate - metabolism</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biotransformation</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Carcinogens - pharmacokinetics</topic><topic>Chemical agents</topic><topic>dimethyl sulphoxide</topic><topic>dithiothreitol</topic><topic>DMSO</topic><topic>DNA - metabolism</topic><topic>DTT</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>GSH</topic><topic>Humans</topic><topic>Imidazoles - pharmacokinetics</topic><topic>Kinetics</topic><topic>Male</topic><topic>Medical sciences</topic><topic>N-hydroxy-2-amino-1-methyl-6-phenylimidazo</topic><topic>N-Hydroxy-2-amino-3-methylimidazo(4,5-f)quinoline</topic><topic>N-hydroxy-IQ</topic><topic>N-OH-IQ</topic><topic>N-OH-PhIP</topic><topic>Phosphotransferases - antagonists &amp; inhibitors</topic><topic>PKC</topic><topic>protein kinase C</topic><topic>Quinolines - pharmacokinetics</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>reduced glutathione</topic><topic>Subcellular Fractions - metabolism</topic><topic>Sulfuric Acids - metabolism</topic><topic>tetrahydrofuran</topic><topic>THF</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Agus, Cynthia</creatorcontrib><creatorcontrib>Ilett, Kenneth F.</creatorcontrib><creatorcontrib>Kadlubar, Fred F.</creatorcontrib><creatorcontrib>Minchin, Rodney F.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Carcinogenesis (New York)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Agus, Cynthia</au><au>Ilett, Kenneth F.</au><au>Kadlubar, Fred F.</au><au>Minchin, Rodney F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline</atitle><jtitle>Carcinogenesis (New York)</jtitle><addtitle>Carcinogenesis</addtitle><date>2000-06-01</date><risdate>2000</risdate><volume>21</volume><issue>6</issue><spage>1213</spage><epage>1219</epage><pages>1213-1219</pages><issn>0143-3334</issn><eissn>1460-2180</eissn><coden>CRNGDP</coden><abstract>2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) is one of several mutagenic and carcinogenic heterocyclic amines formed during the cooking process of protein-rich foods. These compounds are highly mutagenic and have been shown to produce tumours in various tissues in rodents and non-human primates. Metabolic activation of IQ is a two-step process involving N-hydroxylation by CYP1A2 followed by esterification to a more reactive species capable of forming adducts with DNA. To date, acetylation and sulphation have been proposed as important pathways in the formation of N-hydroxy esters. In this study we have demonstrated the presence of an ATP-dependent activation pathway for N-hydroxy-IQ (N-OH-IQ) leading to DNA adduct formation measured by covalent binding of [3H]N-OH-IQ to DNA. ATP-dependent DNA binding of N-OH-IQ was greatest in the cytosolic fraction of rat liver, although significant activity was also seen in colon, pancreas and lung. ATP was able to activate N-OH-IQ almost 10 times faster than N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (7.7 ± 0.3 and 0.9 ± 0.1 pmol/mg protein/min, respectively). Using reported intracellular concentrations of cofactor, the ability of ATP to support DNA binding was similar to that seen with 3′-phosphoadenosine 5′-phosphosulphate and ~50% of that seen with acetyl coenzyme A (AcCoA). In addition to DNA binding, HPLC analysis of the reaction mixtures using ATP as co-factor showed the presence of two stable, polar metabolites. With AcCoA, only one metabolite was seen. The kinase inhibitors genistein, tyrphostin A25 and rottlerin significantly inhibited both DNA binding and metabolite formation with ATP. However, inhibition was unlikely to be due to effects on enzyme activity since the broad spectrum kinase inhibitor staurosporine had no effect and the inactive analogue of genistein, daidzein, was as potent as genistein. The effects of genistein and daidzein, which are naturally occurring isoflavones from soy and other food products, on DNA adduct formation may potentially be useful in the prevention of heterocyclic amine-induced carcinogenesis.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>10837012</pmid><doi>10.1093/carcin/21.6.1213</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0143-3334
ispartof Carcinogenesis (New York), 2000-06, Vol.21 (6), p.1213-1219
issn 0143-3334
1460-2180
language eng
recordid cdi_proquest_miscellaneous_17550532
source MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library; Oxford Journals
subjects 2-amino-3-methylimidazo
5-b]pyridine
5-f]quinoline
Acetylation
Adenosine Triphosphate - metabolism
Animals
Biological and medical sciences
Biotransformation
Carcinogenesis, carcinogens and anticarcinogens
Carcinogens - pharmacokinetics
Chemical agents
dimethyl sulphoxide
dithiothreitol
DMSO
DNA - metabolism
DTT
Enzyme Inhibitors - pharmacology
GSH
Humans
Imidazoles - pharmacokinetics
Kinetics
Male
Medical sciences
N-hydroxy-2-amino-1-methyl-6-phenylimidazo
N-Hydroxy-2-amino-3-methylimidazo(4,5-f)quinoline
N-hydroxy-IQ
N-OH-IQ
N-OH-PhIP
Phosphotransferases - antagonists & inhibitors
PKC
protein kinase C
Quinolines - pharmacokinetics
Rats
Rats, Inbred F344
reduced glutathione
Subcellular Fractions - metabolism
Sulfuric Acids - metabolism
tetrahydrofuran
THF
Tumors
title Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T17%3A36%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20an%20ATP-dependent%20pathway%20of%20activation%20for%20the%20heterocyclic%20amine%20carcinogen%20N-hydroxy-2-amino-3-methylimidazo%5B4,5-f%5Dquinoline&rft.jtitle=Carcinogenesis%20(New%20York)&rft.au=Agus,%20Cynthia&rft.date=2000-06-01&rft.volume=21&rft.issue=6&rft.spage=1213&rft.epage=1219&rft.pages=1213-1219&rft.issn=0143-3334&rft.eissn=1460-2180&rft.coden=CRNGDP&rft_id=info:doi/10.1093/carcin/21.6.1213&rft_dat=%3Cproquest_cross%3E17550532%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219309062&rft_id=info:pmid/10837012&rfr_iscdi=true